Dysfunctional mitochondria, disrupted levels of reactive oxygen species, and autophagy in B cells from common variable immunodeficiency patients
Open Access
- 26 March 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1362995
Abstract
Introduction: Common Variable Immunodeficiency (CVID) patients are characterized by hypogammaglobulinemia and poor response to vaccination due to deficient generation of memory and antibody-secreting B cells. B lymphocytes are essential for the development of humoral immune responses, and mitochondrial function, hreactive oxygen species (ROS) production and autophagy are crucial for determining B-cell fate. However, the role of those basic cell functions in the differentiation of human B cells remains poorly investigated.Methods: We used flow cytometry to evaluate mitochondrial function, ROS production and autophagy processes in human naïve and memory B-cell subpopulations in unstimulated and stimulated PBMCs cultures. We aimed to determine whether any alterations in these processes could impact B-cell fate and contribute to the lack of B-cell differentiation observed in CVID patients.Results: We described that naïve CD19+CD27- and memory CD19+CD27+ B cells subpopulations from healthy controls differ in terms of their dependence on these processes for their homeostasis, and demonstrated that different stimuli exert a preferential cell type dependent effect. The evaluation of mitochondrial function, ROS production and autophagy in naïve and memory B cells from CVID patients disclosed subpopulation specific alterations. Dysfunctional mitochondria and autophagy were more prominent in unstimulated CVID CD19+CD27- and CD19+CD27+ B cells than in their healthy counterparts. Although naïve CD19+CD27- B cells from CVID patients had higher basal ROS levels than controls, their ROS increase after stimulation was lower, suggesting a disruption in ROS homeostasis. On the other hand, memory CD19+CD27+ B cells from CVID patients had both lower ROS basal levels and a diminished ROS production after stimulation with anti-B cell receptor (BCR) and IL-21.Conclusion: The failure in ROS cell signalling could impair CVID naïve B cell activation and differentiation to memory B cells. Decreased levels of ROS in CVID memory CD19+CD27+ B cells, which negatively correlate with their in vitro cell death and autophagy, could be detrimental and lead to their previously demonstrated premature death. The final consequence would be the failure to generate a functional B cell compartment in CVID patients.Keywords
This publication has 40 references indexed in Scilit:
- ROS fine-tunes the function and fate of immune cellsInternational Immunopharmacology, 2023
- Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert CommitteeJournal of Clinical Immunology, 2022
- Involvement of Reactive Oxygen Species (ROS) in BCR Signaling as a Second Messenger2020
- Reactive oxygen species: The signal regulator of B cellFree Radical Biology and Medicine, 2019
- B Cell Responses: Cell Interaction Dynamics and DecisionsCell, 2019
- From zero to sixty and back to zero again: the metabolic life of B cellsCurrent Opinion in Immunology, 2019
- Regulation of B cell fate, survival, and function by mitochondria and autophagyMitochondrion, 2018
- Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network RegistryJournal of Allergy and Clinical Immunology, 2018
- Memory B cells: total recallCurrent Opinion in Immunology, 2017
- Common variable immunodeficiency: a new look at an old diseaseThe Lancet, 2008